Previous studies indicate that oxygen radical production by 1-min activation ofN-formyl-methionyl-leucyl-phenylalanine-induced chemiluminescence (CL) by whole blood is increased in subjects with previousYersinia arthritis (YA). This finding is confirmed in the present study and extended further by demonstrating that subjects with previous YA show increased oxygen radical generation and enhanced release of myeloperox dase from neutrophils and increased CL activity by serum, all factors that can contribute to an increase in the initial activation of CL. Initial activation was not increased in subjects who had hadYersinia enteritis without arthritis; however, intracellular oxygen radical production by purified neutrophils was significantly increased, suggesting that the cells had been primed in vivo. The water-soluble antioxidants of plasma samples tested by a peroxyl radical-trapping assay were much the same in subjects with previous YA, in subjects with previousYersinia enteritis without arthritis, and in healthy subjects. The results suggest that aberrations in neutrophil oxygen radical production play a role in the pathogenesis of YA.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Ahvonen, O., K. Sievefs, andK. Aho. 1969. Arthritis associated withYersinia enterocolitica infection.Acta Rheum. Scand. 15:232–253.
Berglöf, F.-E. 1963. Arthritis and intestinal infection.Acta Rheum. Scand. 9:141–149.
Paronen, I. 1948. Reiter's disease: Study of 344 cases observed in Finland.Acta Med. Scand. Suppl. 212:1–114.
Urman, J. D., R. B. Zurier, andN. F. Rothfield. 1977. Reiter's syndrome associated withCampylobacter fetus infection.Ann. Intern. Med. 86:444–445.
Keat, A. 1983. Reiter's syndrome and reactive arthritis in perspective.N. Engl. J. Med. 309:1606–1615.
Aho, K., M. Leirisalc-Repo, andH. Repo. 1985. Reactive arthritis.Clin. Rheum. Dis. 11:25–40.
Brewerton, D. A. 1976. HLA-B27 and the inheritance of susceptibility to rheumatic diseases.Arthritis Rheum. 19:656–668.
Leino, R., R. Vuento, S. Koskimies, M. Viander, andA. Toivanen. 1983. Depressed lymphocyte transformation byYersinia andEschericia coli inYersinia arthritis.Ann. Rheum. Dis. 42:176–181.
Sheldon, P. 1985. Specific cell-mediated responses to bacterial antigens and clinical correlations in reactive arthritis, Reiter's syndrome and ankylosing spondylitis.Immunol. Rev. 86:5–25.
Granfors, K., M. Viljanen, A. Thlikainen, andA. Toivanen. 1980. Persistence of IgM, IgG, and IgA antibodies toYersinia inYersinia arthritis.J. Infect. Dis. 141:424–429.
Lahesmaa-Rantala, R., O.-P. Lehtonen, K. Granfors, andA. Toivanen. 1987. Avidity of anti-Yersinia antibodies in yersiniosis patients with and withoutYersinia-triggered reactive arthritis.Arthritis Rheum. 30:1176–1181.
Lahesmaa-Rantala, R., O.-P. Lehtonen, K. Granfors, andA. Toivanen. 1987. CirculatingYersinia specific immune complexes after acute yersiniosis: A follow up study of patients with and without reactive arthritis.Ann. Rheum. Dis. 46:121–126.
Tertti, R., K. I. Granfors, R. Lahesmaa-Rantala, andA. Toivanen. 1989. Serum opsonic capacity againstYersinia enterocolitica 0∶3 in yersiniosis patients with and without reactive arthritis.Clin. Exp. Immunol. 76:227–232.
Ristola, M. 1990. Increased oxygen radical production determined by whole blood chemiluminescence in patients with previousYersinia arthritis.APMIS 98:125–130.
Allen, R. C. 1986. Phagocytic leukocyte oxygenation activities and chemiluminescence: A kinetic approach to analysis.Methods Enzymol. 133:449–493.
Edwards, S. W. 1987. Luminol- and lucigenin-dependent chemiluminescence of neutrophils: Role of degranulation.J. Clin. Lab. Immunol. 22:35–39.
Dahlgren, C. 1988. Effects on extra- and intracellulary localized, chemoattractant-induced, oxygen radical production of neutrophils following modulation of conditions for ligand-receptor interaction.Inflammation 12:335–349.
Leirisalo-Repo, M., andH. Suoranta. 1988. Ten-year followup study of patients withYersinia arthritis.Arthritis Rheum. 31:533–537.
Leirisalo-Repo, M. 1984. Clinical picture of reactive arthritis.Scand. J. Rheumatol. Suppl. 52:65–69.
Ristola, M., andH. Repo. 1989. Luminol-enhanced chemiluminescence of whole blood: Statistical analysis, and comparison of the responses of different subjects.APMIS 97:503–512.
Boyum, A. 1974. Separation of blood leukocytes, granulocytes, and lymphocytes.Tissue Antigens 4:269–274.
Andrews, P. C., andN. I. Krinsky. 1986. Human myeloperoxidase and hemi-myeloperoxidase.Methods Enzymol. 132:369–378.
Wayner, D. D. M., G. W. Burton, K. U. Ingold, andS. Locke. 1985. Quantitative measurement of total, peroxyl radical-trapping antioxidant capability of human blood plasma by controlled peroxidation, the important contribution made by plasma proteins.FEBS Lett. 187:33–37.
Wayner, D. D. M., G. W. Burton, U. K. Ingold, L. R. C. Barclay, andS. J. Locke. 1987. The relative contribution of vitamin E, urate, ascorbate, and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma.Biochim. Biophys. Acta 924:408–419.
Marklund, S. L., H. Repo, andS. Koskimies. 1987. Superoxidase dismutase isoenzymes, glutathione peroxidase and selenium in blood from HLA-B27-positive and -negative subjects.Acta Pathol. Microbiol. Immunol. Scand. Sect. C 95:107–111.
Granfors, K., S. Jalkanen, R. von Essen, R. Lahesmaa-Rantala, O. Isomäki, K. Pekkola-Heino, R. Merilahti-Palo, R. Saario, H. Isomäki, andA. Toivanen. 1989.Yersinia antigens in synovial-fluid cells from patients with reactive arthritis.N. Engl. J. Med. 320:216–221.
Hoogkamp-Korstanje, J. A., J. de Koning, andJ. Hesseman. 1988. Persistence ofYersinia enterocolitica in man.Infection 16:81–85.
Bass, D. A., P. Olbrantz, P. Szejda, M. C. Seeds, andC. E. McCall. 1986. Subpopulation of neutrophils with increased oxidative product formation in blood of patients with infection.J. Immunol. 136:860–886.
Briheim, G., P. Follin, S. Sandstedt, andC. Dahlgren. 1989. Relationship between intracellularly and extracellularly generated oxygen metabolites from primed polymorphonuclear leukocytes differs from that obtained from nonprimed cells.Inflammation 13:455–464.
Edwards, S. W., H. L. Nurcombe, andC. A. Hart. 1987. Oxidative inactivation of myeloperoxidase released from human neutrophils.Biochem. J. 245:925–928.
van Bohemen, C. G., A. J. J. M. Nabbe, J. E. Landheer, F. C. Grumet, E. S. Mazurkiewicz, H. J. Dinant, R. J. Lionarons, P. C. van Bogedom, andH. C. Zanen. 1986. HLA-B27M1M2 and high immune responsiveness toShigella flexneri in post dysenteric arthritis.Immunol. Lett. 13:71–74.
Chen, J.-H., D. H. Kono, Z. Yong, M. S. Park, M. M. B. A. Oldstone, andD. T. Y. Yu. 1987.Yersinia pseudotuberculosa protein which crossreacts with HLA-B27.J. Immunol. 139:3003–3011.
Geczy, A. F., L. E. McGuigan, J. S. Sullivan, andJ. P. Edmonds. 1986. Cytotoxic T lymphocytes against disease associated determinant(s) in ankylosing spondylitis.J. Exp. Med. 164:932–937.
Leirisalo, M., H. Repo, A. Tiilikainen, T. U. Kosunen, andO. Laitinen. 1980. Chemotaxis inYersinia arthritis. HLA-B27 positive neutrophils show high stimulated motility in vitro.Arthritis Rheum. 23:1036–1044.
Repo, H., M. Leirisalo, A. Tiilikainen, andO. Laitinen. 1982. Chemotaxis in yersinia arthritis. In vitro stimulaton of neutrophil migration by HLA-B27 positive and negative sera.Arthritis Rheum. 25:655–661.
Vuento, R., J. Eskola, R. Leino, S. Koskimies, andM. Viander. 1984. IgM, IgG, and IgA synthesis in vitro in persons suffering fromYersinia arthritis and in patients with ankylosing spondylitis.Ann. Rheum. Dis. 43:186–191.
About this article
Cite this article
Ristola, M., Metsä-Ketelä, T., Leirisalo-Repo, M. et al. Oxygen radical production and trapping in subjects with previousYersinia infection. Inflammation 16, 273–283 (1992). https://doi.org/10.1007/BF00918816
- Public Health
- Internal Medicine
- Healthy Subject